IP Library › Granted Patent US 12,250,944
Granted Patent B2
US 12,250,944 · App. 16/757,013 · Granted Mar 18, 2025

High-fidelity long-term storage of biological material

Inventors: Maurice Chapellier (Gif-sur-Yvette, FR); Fabrice Chretien (Paris, FR); Fabrice Piquemal (Le Barp, FR); Pierre Rocheteau (Paris, FR); Guillaume Warot (Modane, FR); Michel Zampaolo (Saint Ismier, FR)
Assignees: Centre National de la Recherche Scientifique (CNRS); Institut Pasteur; Université Paris Cité; Groupe Hospitalier Universitaire Paris—Psychiatrie et Neurosciences
A01N1/0257A01N1/0268A01N1/0278G21F5/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,250,944
App. No.
16/757,013
Granted
Mar 18, 2025
Kind
B2
Abstract

The present invention relates to the long-term preservation of biological material. More specifically, it concerns a preservation container comprising: a biological container for containing biological material, a first shield configured for absorbing gamma-rays, a second shield configured for absorbing ambient neutrons, said second shield surrounding the biological container, the preservation container being of low-radioactivity background materials, and a method for preserving a biological material, comprising: a) providing a biological material in a confinement container, b) providing the preservation container of the invention, c) placing the confinement container containing the biological material into said preservation container, d) storing said preservation container containing the biological material in a room located under a material attenuating cosmic rays and induced particles, said material having a thickness equivalent to 1 m to 7000 m of water, for attenuating cosmic rays.

Claims (42)

1. A preservation container comprising:

a biological container for containing biological material;

a first shield configured for absorbing gamma-rays, wherein the first shield has a gamma-ray attenuation factor equivalent to 10 cm to 15 cm of lead; and

a second shield configured for absorbing ambient neutrons, said second shield surrounding the biological container, wherein the second shield has a neutron attenuation factor equivalent to 30 to 100 cm of water;

the preservation container being of low-radioactivity background materials, wherein the materials have a radioactivity of 10 Bq/kg or less, and

wherein a radon-free fluid, being a fluid having radioactivity of less than 0.1 Bq/m 3 due to radon, stands and/or circulates around and/or within the biological container, wherein the radon-free fluid comprises radon-free air, radon-free nitrogen, or radon-free argon.

2. The preservation container of claim 1 , wherein

the first shield is located between the biological container and the second shield, or

the second shield surrounds the biological container and is located within the first shield.

3. The preservation container of claim 1 , wherein it further comprises a cryogenic container, said cryogenic container containing a cold source and defining a chamber for containing the biological container.

4. The preservation container of claim 3 , wherein:

the first shield surrounds the biological container and is located within the cryogenic container, or

the first shield is located between the cryogenic container and the second shield, or

the second shield is located within the first shield.

5. The preservation container of claim 4 , wherein the first shield surrounds the biological container and is located within the cryogenic container, and the second shield surrounds the cryogenic container.

6. The preservation container of claim 3 , wherein the cold source is a heat engine, or a cryogenic fluid comprising liquid nitrogen or argon.

7. A method for preserving a biological material, comprising:

a) providing a biological material in a confinement container,

b) providing the preservation container of claim 1 ,

c) placing the confinement container containing the biological material into the biological container of said preservation container,

d) storing said preservation container containing the biological material in a room located under a material attenuating cosmic rays and induced particles, said material having a thickness equivalent to 1 m to 7000 m of water, for attenuating cosmic rays.

8. The method of claim 7 , wherein the material attenuating cosmic rays is earth, rock, water and/or concrete.

9. The method of claim 8 , wherein the radon-free fluid is a fluid having radioactivity of less than 0.1 Bq/m 3 due to radon.

10. The method of claim 7 , wherein

the radon-free fluid is a fluid having radioactivity of less than 0.1 Bq/m 3 due to radon, and/or

the room contains an atmosphere of less than 1 Bq/m 3 .

11. The method of claim 10 , wherein

the atmosphere of less than 0.1 Bq/m 3 is a radon-free atmosphere.

12. The method of claim 7 , wherein the biological material is a data storage material.

13. The method of claim 12 , wherein the data storage material comprises DNA, RNA, a peptide, a protein, a virus, or a bacterium or any combination thereof.

14. The method of claim 7 , wherein the preservation container further comprises a cryogenic container comprising a cold source and a chamber containing the biological container, said biological container being cooled by the cold source,

and wherein step c) comprises cooling the biological material by placing the confinement container in the biological container.

15. The method of claim 14 , wherein the biological container is frozen by placing it within or in freezing proximity to the cold source.

16. The method of claim 14 , wherein the biological material is:

a peptide, a protein, DNA, or RNA;

a pluripotent stem cell, an induced pluripotent stem cell, or a gamete;

a seed, a spore, or a pollen;

a larvae, an insect, a bacterium, a virus; or

a tissue, an organ, body parts or a whole animal body.

17. The preservation container of claim 1 wherein the second shield comprises polyethylene containing at least 14 wt % of hydrogen atom, hydrogen containing polyolefins, paraffin, or wood, or any combination thereof.

18. The preservation container of claim 17 , further comprising a cryogenic container, said cryogenic container containing a cold source and defining a chamber for containing the biological container, wherein the cold source is a heat engine, or a cryogenic fluid comprising liquid nitrogen or argon.

19. System for preserving a biological material comprising the preservation container containing the biological material of claim 1 and further comprising a room located under a material attenuating cosmic rays and induced particles, said material having a thickness equivalent to 1 m to 7000 m of water, for attenuating cosmic rays, the preservation container containing the biological material is located within the room.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2023
From: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS); INSTITUT PASTEUR
To: UNIVERSITÉ PARIS CITÉ; GROUPE HOSPITALIER UNIVERSITAIRE PARIS - PSYCHIATRIE ET NEUROSCIENCES
Reel/Frame 063386/0494 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2023
From: CHRETIEN, FABRICE
To: UNIVERSITÉ PARIS CITÉ; GROUPE HOSPITALIER UNIVERSITAIRE PARIS - PSYCHIATRIE ET NEUROSCIENCES
Reel/Frame 063322/0779 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY NUMBER 16930208 PREVIOUSLY RECORDED AT REEL: 060541 FRAME: 0336. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER AND CHANGE OF NAME. Recorded Jan 11, 2023
From: UNIVERSITE PARIS DESCARTES; UNIVERSITE PARIS DIDEROT - PARIS 7
To: UNIVERSITE DE PARIS
Reel/Frame 062387/0346 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY NUMBER 16930208 PREVIOUSLY RECORDED AT REEL: 060390 FRAME: 0122. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Jan 11, 2023
From: UNIVERSITE DE PARIS
To: UNIVERSITÉ PARIS CITÉ
Reel/Frame 062387/0489 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 12, 2022
From: CHAPELLIER, MAURICE; PIQUEMAL, FABRICE; WAROT, GUILLAUME; ZAMPAOLO, MICHEL
To: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
Reel/Frame 060482/0512 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 12, 2022
From: ROCHETEAU, PIERRE
To: INSTITUT PASTEUR
Reel/Frame 060636/0221 →
MERGER AND CHANGE OF NAME Recorded Jun 20, 2022
From: UNIVERSITE PARIS DESCARTES; UNIVERSITE PARIS DIDEROT - PARIS 7; UNIVERSITE DE PARIS
To: UNIVERSITE DE PARIS
Reel/Frame 060541/0336 →
CHANGE OF NAME Recorded Jun 20, 2022
From: UNIVERSITE DE PARIS
To: UNIVERSITÉ PARIS CITÉ
Reel/Frame 060390/0122 →
Priority Claims (1)
EP 17306409 · Oct 18, 2017 · regional
Continuity (1)
Related Publication 20200337299A1 · Oct 29, 2020
References Cited (51)
US 681400A · McCarty · 1901 [cited by examiner]
US 8883719B2 · Birge et al. · 2014 [cited by applicant]
US 10648964B2 · Rice · 2020 [cited by examiner]
US 20080269549A1 · Taft · 2008 [cited by examiner]
US 20150048085A1 · Brown · 2015 [cited by examiner]
US 20160341711A1 · Rice et al. · 2016 [cited by applicant]
KR 20100106261A · 2010 [cited by examiner]
WO 2004033729A1 · 2004 [cited by applicant]
Theodorsson, Pall, Measurement of Weak Radioactivity, 1996, pp. 155 (Year: 1996). [cited by examiner]
KR20100106261A—Choi Machine English Translation Description (Year: 2010). [cited by examiner]
Nuclear Regulatory Commission) NRC.gov—PowerPoint Presentation: Basic Health Physics, Shielding Radiation (2011). (Year: 2011). [cited by examiner]
Theodorsson, Pall, Measurement of Weak Radioactivity, 1996, pp. 156 (Year: 1996). [cited by examiner]
Kreuzer, et al., (Year: 2010). [cited by examiner]
Plummer et al. (Year: 1998). [cited by examiner]
Pacific News Center, “U.S. EPA: Radiation Sensors Confirm “No Radiation Levels of Concern” Anywhere in U.S.” p. 1 (Year: 2011). [cited by examiner]
Pacific News Center, “U.S. EPA: Radiation Sensors Confirm “No Radiation Levels of Concern” Anywhere in U.S.” p. 2 (Year: 2011). [cited by examiner]
Measure of Weak Radioactivity—Theodorsson (Year: 1996). [cited by examiner]
(Nuclear Regulatory Commission) NRC.gov—PowerPoint Presentation: Basic Health Physics, Shielding Radiation (Year: 2011). [cited by examiner]
Pacific News Center (Year: 2011). [cited by examiner]
Plummer (Year: 1998). [cited by examiner]
KR20100106261A—Choi Machine Translation (Year: 2010). [cited by examiner]
Sambasivan et al. Distinct Regulatory Cascades Govern Extraocular and Pharyngeal Arch Muscle Progenitor Cell Fates. Dev. Cell 16, 810-821 (2009). [cited by applicant]
Rocheteau et al. A subpopulation of adult skeletal muscle stem cells retains all template DNA strands after cell division. Cell 148, 112-125 (2012). [cited by applicant]
Hoeijmakers, J. H. Genome maintenance mechanisms for preventing cancer. Nature 411, 366-74 (2001). [cited by applicant]
Rothkamm et al. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc. Natl. Acad. Sci. U. S. A. 100, 5057-62 (2003). [cited by applicant]
Mohrin et al. Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell 7, 174-185 (2010). [cited by applicant]
Ferdousi et al. More efficient repair of DNA double-strand breaks in skeletal muscle stem cells compared to their committed progeny. Stem Cell Res. 13, 492-507 (2014). [cited by applicant]
Sotiropoulou et al. Bcl-2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death. Nat. Cell Biol. 12, 572-582 (2010). [cited by applicant]
Weinstock et al. Modeling oncogenic translocations: Distinct roles for double-strand break repair pathways in translocation formation in mammalian cells. DNA Repair (Amst). 5, 1065-1074 (2006). [cited by applicant]
Wyman et al. DNA double-strand break repair: all's well that ends well. Annu. Rev. Genet. 40, 363-83 (2006). [cited by applicant]
Cory et al. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22, 8590-607 (2003). [cited by applicant]
Jang et al. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 110, 3056-3063 (2007). [cited by applicant]
Owusu-Ansah et al. Reactive oxygen species prime [cited by applicant]
Dansen et al. Redox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity. Nat. Chem. Biol. 5, 664-72 (2009). [cited by applicant]
Seale et al. Pax7 is required for the specification of myogenic satellite cells. Cell 102, 777-786 (2000). [cited by applicant]
Zammit et al.The skeletal muscle satellite cell: the stem cell that came in from the cold. J. Histochem. Cytochem. Off. J. Histochem. Soc. 54, 1177-1191 (2006). [cited by applicant]
Deprimo et al. Human placental alkaline phosphatase as a histochemical marker of gene expression in transgenic mice. Transgenic Res. 5, 459-66 (1996). [cited by applicant]
Kelly et al. Myosin light chain 3F regulatory sequences confer regionalized cardiac and skeletal muscle expression in transgenic mice. J. Cell Biol. 129, 383-396 (1995). [cited by applicant]
Beauchamp et al. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell Biol. 144, 1113-1121 (1999). [cited by applicant]
Ziegler, J.F. Terrestrial cosmic rays IBM J. Res. Develop. 40 No. Jan. 1, 1996. [cited by applicant]
Mei et al. Muon-induced background study for underground laboratories. Phys. Rev. D 73, 053004 (2006). [cited by applicant]
Gordon et al. Measurement of the Flux and Energy Spectrum of Cosmic-Ray Induced Neutrons on the Ground IEEE Transactions on Nuclear Science, vol. 51, No. 6, Dec. 2004. [cited by applicant]
Elmahroug et al. “Calculation of Fast Neutron Removal Cross-Sections for Different Shielding Materials” International Journal of Physics and Research (IJPR) ISSN 2250-0030 vol. 3, Issue 2, Jun. 2013, 7-16. [cited by applicant]
Cox, Jonathan PL. Long-term data storage in DNA. Trends in Biotechnology 19, 7 (2001), 247-250. [cited by applicant]
Yachie et al. Alignment-based approach for durable data storage into living organisms. Biotechnology progress 23, 2 (2007), 501-505. [cited by applicant]
Woods et al. “Off the shelf cellular therapeutics: factors to consider during cryopreservation and storage of human ceels for clinical use”. Cytotherapy, 18(6), 2016, 697-711. [cited by applicant]
Cugia et al. “High Survival of Frozen Cells Irradiated with Gamma Radiation”. Radiation Protection Dosimetry, 143 (2-4), 2010, 237-240. [cited by applicant]
Bottigli et al. “Effect of cryo-preservation on the response of different biological systems to g-ray exposure: A feasibility study”. Nuovo Cimento, 31(1), 2008, 11-20. [cited by applicant]
Desrosiers et al. “Membranous and structural damage that occur during cryopreservation of human sperm may be time-related events”. Fertility and sterility, 85(6), 2006, 1744-1752. [cited by applicant]
Tellili et al. “Calculation of fast neutron removal cross sections for different lunar soils”. Advances in Space Search 53 (2014) 348-352. [cited by applicant]
Limbachiya et al. “Natural Data Storage: A Review on sending Information from now to then via Nature” ACM Journal on Emerging Technologies in Computing Systems, May 19, 2015, pp. A:1-A:17. [cited by applicant]